Eradicating ‘Indication Creep’ One Of Eight Australian Proposals To Tackle Opioid Misuse
Executive Summary
Australian regulators are proposing to review the indications of strong opioids to see if they are appropriate, according to one of eight regulatory options for addressing the growing problem of opioid misuse in the country.
You may also be interested in...
Opioid Indications Under TGA Scrutiny As Australia Tackles Growing Misuse
The Australian drug regulator is reviewing the indications, pack sizes and information documents for consumers of potent opioid products to see how misuse and overdoses can be prevented.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.